Yates, Traci D.
Davis, Marion E.
Taylor, Yhenneko J.
Davidson, Lisa
Connor, Crystal D.
Buehler, Katherine
Spencer, Melanie D.
Funding for this research was provided by:
The Duke Endowment (6577-SP)
Article History
Received: 2 March 2018
Accepted: 31 May 2018
First Online: 23 June 2018
Ethics approval and consent to participate
: This study was reviewed and approved by the Atrium Health Institutional Review Board. The Atrium Health Institutional Review Board determined that the project activities described in a quality improvement vs. research screening form fell into the category of quality improvement. The grant application outlining the study activities was also reviewed and deemed to be quality improvement. Per Atrium Health IRB policy, the project and all activities therein were therefore not required to act in accordance with research policies and regulations. Although it was deemed to be a quality improvement project, subjects were verbally consented to provide confirmation that there was an understanding of the objectives of the interview, that the subjects themselves were willing and able to participate, and that they could decline to participate further at any time.
: M.D.S. reports a research grant from Eli Lilly and Company. The authors have no other relationships or activities that could appear to have influenced the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.